STATEMENT: Patients For Affordable Drugs Responds to Consolidated Oral Arguments Made In First Appeal Heard Against Medicare Negotiation
ICYMI: Patients Score Eighth Legal Victory As Court Rejects Novartis Challenge to Medicare Negotiation Program
NBC News Reports Soaring Medication Costs Force Patients Of Color To Make Impossible Choices
District Court Will Now Hear A Suit On The Merits–Like The Industry Has Lost In Every Other Jurisdiction
P4AD Counters Industry’s Legal Arguments, Recounts The Sordid History Of Big Pharma’s Opposition To Medicare Negotiation And Tells The Court Of The IRA’s Positive Impact On Millions Of Patients
Patients Champion The Law’s Drug Price Reforms, Share How Their Lowered Rx Prices Will Be Game-changing
Today, following the announcement of the new lower prices negotiated through Medicare – which marked a historic shift in drug pricing policy – P4AD patient advocate Judy Aiken, who takes Enbrel, one of the first 10 negotiated drugs, introduced President Biden and Vice President Harris at an event focused on the new lowered prices.
Today, the Biden-Harris administration released the results of its first-ever drug price negotiations through Medicare, marking a historic shift in drug pricing policy and promising significant savings for nearly nine million American patients.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
